Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors

Indian Journal of Medical Research

Volumn 124, Issue OCT., 2006, Pages 431-438

  Thakral, Beenu ^a   Marwaha, Neelam ^a   Chawla, Y K ^a   Saluja, Karan ^a   Sharma, Arpita ^a   Sharma, R R ^a   Minz, R W ^a   Agnihotri, S K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anti HCV; Autoantibodies; HCV viraemia; LFT; Risk factors

Indexed keywords

AMINOTRANSFERASE; CRYOGLOBULIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS RNA;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; COUNSELING; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH EDUCATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RISK; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALARIA; PREVALENCE; QUALITATIVE ANALYSIS; QUESTIONNAIRE; RISK FACTOR; RNA ANALYSIS; SAFETY; SCREENING TEST; SURGICAL TECHNIQUE; VENEREAL DISEASE REACTION TEST; VIREMIA; VIRUS TRANSMISSION; ADOLESCENT; BLOOD; DISEASE TRANSMISSION; EPIDEMIOLOGY; GENETICS; IMMUNOLOGY; INDIA; ISOLATION AND PURIFICATION; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; BASE SEQUENCE; BLOOD DONORS; BLOOD TRANSFUSION; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INDIA; MIDDLE AGED; PROSPECTIVE STUDIES; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 34247164468     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Barth H, Liang TJ, Baumert TF. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 2006; 44: 527-35.
2. Memon MI, Memon MA. Hepatitis C: An epidemiological review. J Viral Hepat 2002; 9: 84-100.
3. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S, et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver disease. J Med Virol 1997; 51: 167-74.
4. Garson JA, Tedder RS, Briggs M, Tuke P, Glazebrook JA, Trute A, et al. Detection of hepatitis C virus sequences in blood donations by 'nested' polymerase chain reaction and prediction of infectivity. Lancet 1990; 335: 1419-22.
5. Shakil OA, Alter JH, Hayashi P, Kleiner ED, Tedeschi V, Conjeevaram SH, et al. Volunteer blood donors with antibody to hepatitis C virus: Clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995; 123: 330-7.
6. Esteban JI, Lopez Talavera JC, Genesca J, Madoz P, Viladomiu L, Muniz E, et al. High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus. Ann Intern Med 1991; 115: 443-9.
7. Nalpas B, Romeo R, Pol S, Thiers V, Carnot F, Berthelot P, et al. Serum hepatitis C virus (HCV) RNA: A reliable tool for evaluating HCV related liver disease in anti HCV positive blood donors with persistently normal alanine aminotransferase values. Transfusion 1995; 35: 750-3.
8. McMurray RW. Hepatitis C associated autoimmunity. In: Lahita RG, Choazzi N, Reevers WH, editors. Textbook of the autoimmune diseases, 1st ed. Philadelphia: Lippincot Williams and Wilkins; 2000 p. 669-78.
9. Chan SW, Mc Ownish F, Holmes EC, Dow B, Peutherer JF, Follett E, et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-41.
10. Tyler VV, Brecher ME, Butch SH, Calhoun AR, Fiebig EW, Goodnough LT, Hahn L, Ladd DJ, McKenna L, Peters HJ, Pierce SR, Rearden A, South SF, Storry JR, et al, editors. Technical manual, 13th ed. Maryland: American Association of Blood Banks; 2000 p. 602.
11. Makroo RN, Raina V, Kaushik V. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Med Res 1999; 110: 123-5.
12. Choudhury N, Ramesh V, Saraswat S, Naik S. Effectiveness of mandatory transmissible diseases screening in Indian blood donors. Indian J Med Res 1995; 101: 229-32.
13. Jain A, Rana SS, Chakravarty P, Gupta RK, Murthy NS, Nath MC, et al. The prevalence of hepatitis C virus antibodies among the voluntary blood donors of New Delhi, India. Eur J Epidemiol 2003; 18: 695-7.
14. Arankalle VA, Chadha MS, Jha J, Amrapurkar DN, Banerjee K. Prevalence of anti HCV antibodies in Western India. Indian J Med Res 1995; 101: 91-3.
15. Deshpande A, Kumar A, Khodaiji S, Gupta AD. Prevalence of hepatitis C virus antibody in healthy blood donors. Indian J Hemat Blood Transf 1998; 16: 71-2.
16. Nanu A, Sharma SP, Chatterjee K, Jyoti P. Markers for transfusion transmissible infections in north Indian voluntary and replacement blood donors: Prevalence and trends 1989-1996. Vox Sang 1997; 73: 70-3.
17. Pereira A, Sanz C, Tassies D, Ramirez B. Do patient related blood donors represent a threat to the safety of the blood supply? Haematologica 2002; 87: 427-33.
18. Malik V. Drugs and Cosmetics Act, 1940. 16th ed. New Delhi: Eastern Book Company; 2003 p. 279-303.
19. Schreiber GB, Glynn SA, Busch MP, Sharma UK, Wright DJ, Kleinman SH. Incidence rates of viral infection among repeat donors: Are frequent donor safer; Retrovirus Epidemiology Donor Study. Transfusion 2001; 41: 730-5.
20. Okayama A, Stuver SO, Tabor E, Tachibana N, Kohara M, Mueller NE, et al. Incident hepatitis C virus infection in a community-based population in Japan. J Viral Hepat 2002; 9: 43-51.
21. Chowdhury A, Santra A, Chaudhari S, Dhali GP, Chaudhari S, Maity SG, et al. Hepatitis C virus infection in the general population: A community-based study in West Bengal, India. Hepatology 2003; 37: 802-9.
22. Cantilena C, Van Raden M, Gibble J, Melpolder J, Shakil OA, Viladomia L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-6.
23. Yoshimura E, Hayashi J, Tani Y, Ohmiya M, Nakashima K, Ikematsu H, et al. Inverse correlation between the titer of antibody to hepatitis C virus and the degree of hepatitis C viremia. J Infect 1994; 29: 147-55.
24. Pearlman BL. Hepatitis C treatment update. Am J Med 2004; 117: 344-52.
25. Dufour DR, Talastas M, Fernandez MDA, Harris B, Strader DB, Seeff LB. Low positive anti hepatitis C virus enzyme immunoassay results: An important predictor of low likelihood of hepatitis C infection. Clin Chem 2003; 49: 479-86.
26. Hadziyannis SJ. The spectrum of extra hepatic manifestation in hepatitis C infection. J Viral Hepat 1997; 4: 9-28.
27. Mc Murray RN, Elbourne KE. Autoimmune associated disorders with hepatitis C viral infection. Semin Arthritis Rheum 1997; 26: 689-701.
28. Agarwal N, Handa R, Acharya SK, Wali JP, Dinda AK, Aggarwal P. A study of autoimmune markers in hepatitis C infection. Indian J Med Res 2001; 113: 170-4.
29. Homberg JC, Abuaf N, Bernard O, Islam S, Alvarez F, Khalil SH, et al. Chronic active hepatitis associated with anti kidney/liver microsome antibody type 1: A second type of "autoimmune" hepatitis. Hepatology 1987; 7: 1333-9.
30. An Action Plan for Blood Safety. National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India; 2003 p. 35-7.